IMFINZI 50 mg/mL concentrate for solution for infusion

Product Information *

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    No Recent Update
  • Active Ingredients * :

    This medicinal product is subject to additional monitoring.

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

AstraZeneca Pharmaceuticals (Ireland) DAC

AstraZeneca Pharmaceuticals (Ireland) DAC

Company products

Medicine name Active Ingredients Bricanyl Turbohaler Brilique 60 mg film-coated tablets Brilique 90 mg film coated tablets Brilique 90 mg Orodispersible Tablets Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen Casodex 50mg Film-coated Tablets Crestor 5 mg, 10 mg, 20 mg and 40 mg Film-coated Tablets Daxas 250 mcg Film-Coated Tablets Daxas 500 mcg Film-coated Tablets Fasenra 30 mg solution for injection in pre filled syringe Fasenra 30 mg solution for injection in pre-filled pen Faslodex Fluenz Tetra nasal spray suspension Forxiga 10 mg Film coated tablets Forxiga 5 mg film coated tablets IMFINZI 50 mg/mL concentrate for solution for infusion IRESSA 250 mg film-coated tablets Komboglyze 2.5mg-1000mg Tablets Komboglyze 2.5mg-850mg Tablets Lokelma 10 g powder for oral suspension Lynparza 100 mg and 150 mg Film-Coated Tablets Lynparza 50 mg hard capsules NIF-TEN 50mg/20mg Capsules Onglyza 2.5 mg Film-Coated Tablets Onglyza 5 mg Film-Coated Tablets